Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.250
+0.030 (2.46%)
May 14, 2025, 9:40 AM - Market open
Traws Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 21.34 | 20.82 | 38.76 | 55.07 | 19.03 | Upgrade
|
| Cash & Short-Term Investments | 21.34 | 20.82 | 38.76 | 55.07 | 19.03 | Upgrade
|
| Cash Growth | 2.48% | -46.28% | -29.62% | 189.46% | -16.29% | Upgrade
|
| Accounts Receivable | - | - | 0.03 | 0.03 | 0.04 | Upgrade
|
| Other Receivables | 1.77 | 0.02 | - | - | - | Upgrade
|
| Receivables | 1.77 | 0.02 | 0.03 | 0.03 | 0.04 | Upgrade
|
| Inventory | - | 0.19 | 0.1 | 0.03 | 0.09 | Upgrade
|
| Prepaid Expenses | 0.16 | 0.17 | 0.19 | 0.25 | 0.26 | Upgrade
|
| Other Current Assets | 1.69 | 1.46 | 0.27 | 0.05 | 0.37 | Upgrade
|
| Total Current Assets | 24.95 | 22.66 | 39.35 | 55.43 | 19.78 | Upgrade
|
| Property, Plant & Equipment | 0.01 | 0.02 | 0.02 | 0.04 | 0.05 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | 0.01 | 0.15 | Upgrade
|
| Total Assets | 24.96 | 22.68 | 39.37 | 55.48 | 19.99 | Upgrade
|
| Accounts Payable | 8.19 | 5.62 | 3.86 | 2.76 | 4.83 | Upgrade
|
| Accrued Expenses | 3.12 | 3.38 | 3.96 | 3.13 | 4.96 | Upgrade
|
| Current Unearned Revenue | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | Upgrade
|
| Total Current Liabilities | 11.53 | 9.22 | 8.05 | 6.12 | 10.02 | Upgrade
|
| Long-Term Unearned Revenue | 2.57 | 2.79 | 3.02 | 3.24 | 3.47 | Upgrade
|
| Other Long-Term Liabilities | 42.49 | - | - | - | 0.32 | Upgrade
|
| Total Liabilities | 56.59 | 12.01 | 11.06 | 9.36 | 13.81 | Upgrade
|
| Common Stock | 0.04 | 0.01 | 0.21 | 0.21 | 0.12 | Upgrade
|
| Additional Paid-In Capital | 617.53 | 493.32 | 491.82 | 490.64 | 434.59 | Upgrade
|
| Retained Earnings | -649.15 | -482.63 | -463.68 | -444.72 | -428.56 | Upgrade
|
| Comprehensive Income & Other | -0.04 | -0.02 | -0.03 | -0.01 | 0.01 | Upgrade
|
| Total Common Equity | -31.63 | 10.67 | 28.31 | 46.12 | 6.18 | Upgrade
|
| Shareholders' Equity | -31.63 | 10.67 | 28.31 | 46.12 | 6.18 | Upgrade
|
| Total Liabilities & Equity | 24.96 | 22.68 | 39.37 | 55.48 | 19.99 | Upgrade
|
| Net Cash (Debt) | 21.34 | 20.82 | 38.76 | 55.07 | 19.03 | Upgrade
|
| Net Cash Growth | 2.48% | -46.28% | -29.62% | 189.46% | -16.29% | Upgrade
|
| Net Cash Per Share | 13.74 | 24.80 | 46.34 | 81.79 | 40.99 | Upgrade
|
| Filing Date Shares Outstanding | 5.07 | 0.84 | 0.84 | 0.84 | 0.63 | Upgrade
|
| Total Common Shares Outstanding | 3.65 | 0.84 | 0.84 | 0.84 | 0.5 | Upgrade
|
| Working Capital | 13.42 | 13.44 | 31.3 | 49.32 | 9.76 | Upgrade
|
| Book Value Per Share | -8.66 | 12.70 | 33.82 | 55.18 | 12.45 | Upgrade
|
| Tangible Book Value | -31.63 | 10.67 | 28.31 | 46.12 | 6.18 | Upgrade
|
| Tangible Book Value Per Share | -8.66 | 12.70 | 33.82 | 55.18 | 12.45 | Upgrade
|
| Machinery | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.